Jensen HH - Search Results

1

Potent fluoro-oligosaccharide probes of adhesion in Toxoplasmosis.

Allman SA, Jensen HH, Vijayakrishnan B, Garnett JA, Leon E, Liu Y, Anthony DC, Sibson NR, Feizi T, Matthews S, Davis BG. Allman SA, et al. Among authors: jensen hh. Chembiochem. 2009 Oct 12;10(15):2522-9. doi: 10.1002/cbic.200900425. Chembiochem. 2009. PMID: 19750531

2

Expanding the diversity of chemical protein modification allows post-translational mimicry.

van Kasteren SI, Kramer HB, Jensen HH, Campbell SJ, Kirkpatrick J, Oldham NJ, Anthony DC, Davis BG. van Kasteren SI, et al. Among authors: jensen hh. Nature. 2007 Apr 26;446(7139):1105-9. doi: 10.1038/nature05757. Nature. 2007. PMID: 17460675

3

Synthesis of N-alkylated noeurostegines and evaluation of their potential as treatment for Gaucher's disease.

Rasmussen TS, Allman S, Twigg G, Butters TD, Jensen HH. Rasmussen TS, et al. Among authors: jensen hh. Bioorg Med Chem Lett. 2011 Mar 1;21(5):1519-22. doi: 10.1016/j.bmcl.2010.12.106. Epub 2011 Jan 8. Bioorg Med Chem Lett. 2011. PMID: 21292481

4

Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin.

Lillelund VH, Jensen HH, Liang X, Bols M. Lillelund VH, et al. Among authors: jensen hh. Chem Rev. 2002 Feb;102(2):515-53. doi: 10.1021/cr000433k. Chem Rev. 2002. PMID: 11841253 Review. No abstract available.

5

The disarming effect of the 4,6-acetal group on glycoside reactivity: torsional or electronic?

Jensen HH, Nordstrøm LU, Bols M. Jensen HH, et al. J Am Chem Soc. 2004 Aug 4;126(30):9205-13. doi: 10.1021/ja047578j. J Am Chem Soc. 2004. PMID: 15281809

6

Azasugar inhibitors as pharmacological chaperones for Krabbe disease.

Hill CH, Viuff AH, Spratley SJ, Salamone S, Christensen SH, Read RJ, Moriarty NW, Jensen HH, Deane JE. Hill CH, et al. Among authors: jensen hh. Chem Sci. 2015 May 20;6(5):3075-3086. doi: 10.1039/c5sc00754b. Epub 2015 Mar 30. Chem Sci. 2015. PMID: 26029356 Free PMC article.

7

Synthesis of uronic-noeurostegine--a potent bacterial β-glucuronidase inhibitor.

Rasmussen TS, Koldsø H, Nakagawa S, Kato A, Schiøtt B, Jensen HH. Rasmussen TS, et al. Among authors: jensen hh. Org Biomol Chem. 2011 Oct 26;9(22):7807-13. doi: 10.1039/c1ob06038d. Epub 2011 Sep 27. Org Biomol Chem. 2011. PMID: 21952673

8

Going to extremes: "super" armed glycosyl donors in glycosylation chemistry.

Jensen HH, Pedersen CM, Bols M. Jensen HH, et al. Chemistry. 2007;13(27):7576-82. doi: 10.1002/chem.200700947. Chemistry. 2007. PMID: 17705330 Review.

9

Synthesis and evaluation of cardiac glycoside mimics as potential anticancer drugs.

Jensen M, Schmidt S, Fedosova NU, Mollenhauer J, Jensen HH. Jensen M, et al. Among authors: jensen hh. Bioorg Med Chem. 2011 Apr 1;19(7):2407-17. doi: 10.1016/j.bmc.2011.02.016. Epub 2011 Feb 16. Bioorg Med Chem. 2011. PMID: 21421322

10

Synthesis and evaluation of galacto-noeurostegine and its 2-deoxy analogue as glycosidase inhibitors.

Salamone S, Clement LL, Viuff AH, Andersen OJ, Jensen F, Jensen HH. Salamone S, et al. Among authors: jensen f, jensen hh. Org Biomol Chem. 2015 Aug 7;13(29):7979-92. doi: 10.1039/c5ob01062d. Epub 2015 Jun 26. Org Biomol Chem. 2015. PMID: 26111992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters